ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lineus Medical and CHS Sign Canadian Distribution Agreement

By: PRLog

FAYETTEVILLE, Ark. & OAKVILLE, Ontario - Jan. 17, 2024 - PRLog -- Lineus Medical is proud to announce the signing of a distribution agreement with the largest independent distributor of vascular access products in Canada, Canadian Hospital Specialties (CHS). CHS is a privately held medical device manufacturer and specialty distributor employing approximately 450 employees and located in Oakville, Ontario. CHS sells medical devices in both the acute care hospital and non-acute healthcare space in Canada and internationally with over 70 sales representatives. Lineus Medical's SafeBreak Vascular, a breakaway device for all IV lines, will now be actively sold in all provinces of Canada.

SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.

Ryan Brick, VP of Sales at Lineus Medical, stated, "We are excited to expand into Canada with the company we consider to be the best vascular access distribution partner in Canada. Sales of SafeBreak are taking off and we believe 2024 will be a breakout year for Lineus. CHS has several hospitals committed to product evaluations in the first half of the year."

Vance Clement, CEO of Lineus Medical, stated, "SafeBreak Vascular was licensed in Canada for all vascular lines down to two weeks of age in August of 2023. We had a quick turnaround in finding the best distributor group to partner with to begin expanding throughout Canada. We believe this distribution partnership will be a great success for both Canadian Hospital Specialties and Lineus Medical.  We are excited to bring our break-away technology for IV lines to patients in Canada"

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.

References

1.      Data on file

Contact
Vance Clement
***@lineusmed.com

Photos: (Click photo to enlarge)

Lineus Medical Logo Vance Clement - CEO of Lineus Medical Ryan Brick - VP of Sales at Lineus Medical Safebreak Installed on a Teenager's Peripheral IV Canadian Hospital Specialties


Source: Lineus Medical

Read Full Story - Lineus Medical and CHS Sign Canadian Distribution Agreement | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.